TRANSCRIPTIONAL AND GENOMIC INTRA‐TUMOR HETEROGENEITY DRIVES SUBCLONE SPECIFIC DRUG RESPONSES IN DIFFUSE LARGE B CELL LYMPHOMA. (12th June 2019) - Roider, T.; Frauhammer, F.; Seufert, J.; Bordas, M.; Stolarczyk, M.; Rabe, S.; Malm, J.; Bruch, P.; Hundemer, M.; Rippe, K.; Goeppert, B.; Seiffert, M.; et al.